Literature DB >> 27489524

A Review of New Surgical and Endoscopic Therapies for Gastroesophageal Reflux Disease.

Robert A Ganz1.   

Abstract

Treatment of gastroesophageal reflux disease in the United States today is binary, with the majority of patients with gastroesophageal reflux disease being treated with antisecre-tory medications and a minority of patients, typically those with volume regurgitation, undergoing Nissen fundoplication. However, there has been increasing dissatisfaction with proton pump inhibitor therapy among a significant number of patients with gastroesophageal reflux disease owing to cost, side effects, and refractory symptoms, and there has been a general reluctance to undergo surgical fundoplication due to its attendant side-effect profile. As a result, a therapy gap exists for many patients with gastroesophageal reflux disease. Alternative techniques are available for these gap patients, including 2 endoscopic fundoplication techniques, an endoscopic radiofrequency energy delivery technique, and 2 minimally invasive surgical procedures. These alternative techniques have been extensively evaluated; however, there are limitations to published studies, including arbitrary definitions of success, variable efficacy measurements, deficient reporting tools, inconsistent study designs, inconsistent lengths of follow-up postintervention, and lack of comparison data across techniques. Although all of the techniques appear to be safe, the endoscopic techniques lack demonstrable reflux control and show variable symptom improvement and variable decreases in proton pump inhibitor use. The surgical techniques are more robust, with evidence for adequate reflux control, symptom improvement, and decreased proton pump inhibitor use; however, these techniques are more difficult to perform and are more intrusive. Additionally, these alternative techniques have only been studied in patients with relatively normal anatomy. The field of gastroesophageal reflux disease treatment is in need of consistent definitions of efficacy, standardized study design and outcome measurements, and improved reporting tools before the role of these techniques can be fully ascertained.

Entities:  

Keywords:  Gastroesophageal reflux disease; Nissen fundoplication; proton pump inhibitor

Year:  2016        PMID: 27489524      PMCID: PMC4969778     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  31 in total

1.  Trends and perioperative outcomes of inpatient antireflux surgery in the United States, 1993-2006.

Authors:  Y R Wang; D T Dempsey; J E Richter
Journal:  Dis Esophagus       Date:  2010-11-12       Impact factor: 3.429

Review 2.  Systematic review: health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease.

Authors:  O Chassany; G Holtmann; J Malagelada; U Gebauer; H Doerfler; K Devault
Journal:  Aliment Pharmacol Ther       Date:  2008-03-20       Impact factor: 8.171

Review 3.  Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis.

Authors:  Kyle A Perry; Ambar Banerjee; William Scott Melvin
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2012-08       Impact factor: 1.719

Review 4.  No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis.

Authors:  Seth Lipka; Ambuj Kumar; Joel E Richter
Journal:  Clin Gastroenterol Hepatol       Date:  2014-10-18       Impact factor: 11.382

5.  Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.

Authors:  Bart P L Witteman; Jose M Conchillo; Nicolaas F Rinsma; Bark Betzel; Andrea Peeters; Ger H Koek; Laurents P S Stassen; Nicole D Bouvy
Journal:  Am J Gastroenterol       Date:  2015-03-31       Impact factor: 10.864

6.  Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial.

Authors:  John G Hunter; Peter J Kahrilas; Reginald C W Bell; Erik B Wilson; Karim S Trad; James P Dolan; Kyle A Perry; Brant K Oelschlager; Nathaniel J Soper; Brad E Snyder; Miguel A Burch; William Scott Melvin; Kevin M Reavis; Daniel G Turgeon; Eric S Hungness; Brian S Diggs
Journal:  Gastroenterology       Date:  2014-10-13       Impact factor: 22.682

7.  Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.

Authors:  Donald O Castell; Peter J Kahrilas; Joel E Richter; Nimish B Vakil; David A Johnson; Seth Zuckerman; Wendy Skammer; Jeffrey G Levine
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

Review 8.  Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.

Authors:  A Becher; H El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2011-07-20       Impact factor: 8.171

Review 9.  Endoscopic therapy of gastroesophageal reflux disease: outcomes of the randomized-controlled trials done to date.

Authors:  Richard I Rothstein
Journal:  J Clin Gastroenterol       Date:  2008 May-Jun       Impact factor: 3.062

Review 10.  Do endoscopic antireflux procedures fit in the current treatment paradigm of gastroesophageal reflux disease?

Authors:  John E Pandolfino; Kumar Krishnan
Journal:  Clin Gastroenterol Hepatol       Date:  2013-06-28       Impact factor: 11.382

View more
  5 in total

1.  Surgical Options for the Treatment of Gastroesophageal Reflux Disease.

Authors:  Tom R DeMeester
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-02

2.  Antireflux mucosectomy band in treatment of refractory gastroesophageal reflux disease: a pilot study for safety, feasibility and symptom control.

Authors:  Laurent Monino; Jean-Michel Gonzalez; Véronique Vitton; Marc Barthet
Journal:  Endosc Int Open       Date:  2020-01-22

3.  Inter-specialty collaboration in the formalization of a new foregut subspecialty.

Authors:  Hannah Vassaur; Peter Martelli
Journal:  PLoS One       Date:  2021-12-30       Impact factor: 3.240

4.  Antireflux band mucosectomy: a novel minimally invasive approach for the treatment of refractory gastroesophageal reflux disease.

Authors:  Ameya Deshmukh; Nasim Parsa; Ahmed Elmeligui; Jose Nieto
Journal:  VideoGIE       Date:  2022-05-14

5.  Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication.

Authors:  Luigi Bonavina; Thomas Horbach; Sebastian F Schoppmann; Janet DeMarchi
Journal:  Surg Endosc       Date:  2020-07-16       Impact factor: 4.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.